Higher tissue expression of S100A2 was significantly correlated with worse overall survival in ovarian cancer patients [15], and S100A2 protein expression in saliva was observed to be higher in oral squamous cell carcinoma patients in comparison to other oral potentially malignant disorders. Here, S100A2 is linked to ovarian cancer.